Literature DB >> 34003335

Immunotherapy in genitourinary cancers: achievements and perspectives.

Evanguelos Xylinas1, Mathieu Roumiguié2, Paul Sargos3.   

Abstract

Entities:  

Year:  2021        PMID： 34003335     DOI： 10.1007/s00345-021-03726-1

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  8 in total

1.  Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma.

Authors:  Ivan Pourmir; Johanna Noel; Audrey Simonaggio; Stéphane Oudard; Yann-Alexandre Vano
Journal:  World J Urol       Date:  2021-01-02       Impact factor: 4.226

2.  Immune checkpoint inhibition in upper tract urothelial carcinoma.

Authors:  Gianluigi Califano; Idir Ouzaid; Paolo Verze; Jean-Francois Hermieu; Vincenzo Mirone; Evanguelos Xylinas
Journal:  World J Urol       Date:  2020-10-31       Impact factor: 4.226

3.  Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions.

Authors:  John L Pfail; Andrew B Katims; Parissa Alerasool; John P Sfakianos
Journal:  World J Urol       Date:  2020-10-15       Impact factor: 4.226

4.  Penile cancer: potential target for immunotherapy?

Authors:  Joren Vanthoor; Gigi Vos; Maarten Albersen
Journal:  World J Urol       Date:  2020-11-03       Impact factor: 4.226

5.  PD-L1 testing in urothelial bladder cancer: essentials of clinical practice.

Authors:  Julien Adam; Yves Allory; Mathieu Rouanne; Camélia Radulescu
Journal:  World J Urol       Date:  2020-11-03       Impact factor: 4.226

6.  Metastatic hormone-sensitive prostate cancer: local treatment strategies.

Authors:  Francesco Montorsi; Alberto Martini; Giorgio Gandaglia; Nicola Fossati; Armando Stabile; Federico Dehò; Andrea Salonia; Alberto Briganti
Journal:  World J Urol       Date:  2021-03-17       Impact factor: 4.226

7.  Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.

Authors:  C Surcel; C Mirvald; G Gandaglia; A Kretschmer; I Tsaur; H Borgmann; Isabel Heidegger; A P Labanaris; I Sinescu; Derya Tilki; G Ploussard; A Briganti; F Montorsi; R Mathieu; M Valerio; V Jinga; D Badescu; D Radavoi; R C N van den Bergh
Journal:  World J Urol       Date:  2020-11-01       Impact factor: 4.226

8.  Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response.

Authors:  Mame Daro-Faye; Wassim Kassouf; Luis Souhami; Gautier Marcq; Fabio Cury; Tamim Niazi; Paul Sargos
Journal:  World J Urol       Date:  2020-09-11       Impact factor: 4.226
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.